Ruxolitinib cream monotherapy demonstrates rapid improvement in the extent and signs of mild to moderate atopic dermatitis across head and neck and other anatomic regions in adolescents and adults: pooled results from 2 phase 3 studies.
Saved in:
| Title: | Ruxolitinib cream monotherapy demonstrates rapid improvement in the extent and signs of mild to moderate atopic dermatitis across head and neck and other anatomic regions in adolescents and adults: pooled results from 2 phase 3 studies. |
|---|---|
| Authors: | Simpson, Eric L.1 (AUTHOR), Bissonnette, Robert2 (AUTHOR), Chiesa Fuxench, Zelma C.3 (AUTHOR), Kallender, Howard4 (AUTHOR), Sturm, Daniel4 (AUTHOR), Ren, Haobo4 (AUTHOR), Stein Gold, Linda F.5 (AUTHOR) |
| Source: | Journal of Dermatological Treatment. Dec2024, Vol. 35 Issue 1, p1-10. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 09546634 |
|---|---|
| DOI: | 10.1080/09546634.2024.2310633 |
